IMMUNOVANT INC (IMVT) Forecast, Price Target & Analyst Ratings

NASDAQ:IMVT • US45258J1025

Current stock price

22.98 USD
-0.67 (-2.83%)
At close:
22.98 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IMMUNOVANT INC (IMVT).

Forecast Snapshot

Consensus Price Target

Price Target
$41.51
+ 80.62% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 27, 2026
Period
Q4 / 2026
EPS Estimate
-$0.61
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
83.48%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$41.51
Upside
+ 80.62%
From current price of $22.98 to mean target of $41.51, Based on 23 analyst forecasts
Low
$22.22
Median
$45.90
High
$59.85

Price Target Revisions

1 Month
3.11%
3 Months
7.09%

Price Target Summary

23 Wall Street analysts provided a forecast for the next 12 months for IMVT. The average price target is 41.51 USD. This implies a price increase of 80.62% is expected in the next year compared to the current price of 22.98.
The average price target has been revised upward by 7.09% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

IMVT Current Analyst RatingIMVT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

IMVT Historical Analyst RatingsIMVT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
83.48%
IMVT was analyzed by 23 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about IMVT.
In the previous month the buy percentage consensus was at a similar level.
IMVT was analyzed by 23 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-10HC Wainwright & Co.Reiterate Buy -> Buy
2026-02-09GuggenheimMaintains Buy -> Buy
2026-01-08Truist SecuritiesMaintains Hold -> Hold
2026-01-06Wolfe ResearchUpgrade Peer Perform -> Outperform
2025-12-15Goldman SachsMaintains Neutral -> Neutral
2025-10-14Truist SecuritiesInitiate Hold
2025-09-30JP MorganMaintains Overweight -> Overweight
2025-09-04HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-12JP MorganMaintains Overweight -> Overweight
2025-08-12B of A SecuritiesMaintains Buy -> Buy
2025-07-28UBSMaintains Neutral -> Neutral
2025-04-22UBSDowngrade Buy -> Neutral
2025-03-20GuggenheimReiterate Buy -> Buy
2025-03-20B of A SecuritiesMaintains Buy -> Buy
2025-03-19HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-10GuggenheimReiterate Buy -> Buy
2025-02-10GuggenheimMaintains Buy -> Buy
2025-02-10HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-07HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-15B of A SecuritiesMaintains Buy -> Buy
2025-01-03Wolfe ResearchDowngrade Outperform -> Peer Perform
2024-12-19Wells FargoMaintains Overweight -> Overweight
2024-11-08HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-10Raymond JamesReiterate Outperform
2024-10-09OppenheimerMaintains Outperform -> Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 27, 2026
Period
Q4 / 2026
EPS Estimate
-$0.61
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
4.01%
Number of Analysts
17

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
5.89%
EPS (3 Months)
18.28%

Next Earnings Summary

IMVT is expected to report earnings on 5/27/2026. The consensus EPS estimate for the next earnings is -0.61 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
IMVT revenue by date.IMVT revenue by date.
N/AN/AN/A
693.25%		N/A
601.01%		N/A
180.43%		N/A
79.91%		N/A
33.09%		N/A
20.91%
EBITDA
YoY % growth
IMVT ebitda by date.IMVT ebitda by date.
N/A-66.06M-108.05M
-63.56%		-155.9M
-44.29%		-208.09M
-33.48%		-269.978M
-29.74%		-437.775M
-62.15%		N/A
-12.85%		N/A
-5.49%		N/A
-3.09%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
IMVT ebit by date.IMVT ebit by date.
-66.08M-108.12M
-63.62%		-156.03M
-44.31%		-208.28M
-33.49%		-270.209M
-29.73%		-438.152M
-62.15%		N/A
-15.09%		N/A
-7.90%		N/A
-2.34%		N/A
57.81%		N/A
374.92%		N/A
155.18%		N/A
44.84%		N/A
28.32%
Operating Margin
IMVT operating margin by date.IMVT operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
IMVT eps by date.IMVT eps by date.
N/A-1.33-1.24
6.77%		-1.43
-15.32%		-1.71
-19.58%		-1.90
-11.11%		-2.74
-44.21%		N/A
1.18%		N/A
1.94%		N/A
0.92%		N/A
59.29%		N/A
400.95%		N/A
213.19%		N/A
44.86%		N/A
32.29%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-0.61
4.01%		-0.71
0.07%		-0.71
2.79%		-0.72
-17.61%		-0.63
-2.38%		-0.55
22.36%		-0.54
23.82%		-0.54
24.64%		-0.54
14.05%
Revenue
Q2Q % growth		44.054MN/AN/AN/AN/A
EBITDA
Q2Q % growth		-119.745M
-5.55%		-123.806M
2.60%		-145.893M
-10.90%		-116.26M
-1.94%		-121.023M
-1.07%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-122.627M
-7.73%		-128.803M
-1.24%		-130.28M
1.12%		-128.019M
-11.94%		-111.471M
9.10%		-117.3M
8.93%		-116.994M
10.20%		-116.688M
8.85%		-116.484M
-4.50%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

IMVT Yearly Revenue VS EstimatesIMVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B
IMVT Yearly EPS VS EstimatesIMVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10 15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
1.31%
EPS Next 5 Year
26.00%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-5.72%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

IMMUNOVANT INC / IMVT Forecast FAQ

What do analysts expect the price target to be for IMMUNOVANT INC (IMVT)?

23 analysts have analysed IMVT and the average price target is 41.51 USD. This implies a price increase of 80.62% is expected in the next year compared to the current price of 22.98.

When does IMMUNOVANT INC (IMVT) report earnings?

IMMUNOVANT INC (IMVT) will report earnings on 2026-05-27, after the market close.

What are the consensus estimates for IMVT stock next earnings?

The consensus EPS estimate for the next earnings of IMMUNOVANT INC (IMVT) is -0.61 USD and the consensus revenue estimate is 0 USD.

What is the consensus rating for IMVT stock?

The consensus rating for IMMUNOVANT INC (IMVT) is 83.4783 / 100 . This indicates that analysts generally have a positive outlook on the stock.